Get the Stockscreener App
60.26
1.62%
-0.99
After Hours:
59.18
-1.08
-1.79%
Verona Pharma Plc Adr Stock (VRNA) Forecast
The Verona Pharma Plc Adr (VRNA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $17.59, representing a -70.81% decrease from the current price of $60.26. The highest analyst price target is $18.93, and the lowest is $16.25.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VRNA Price Target
Average 20.92
(-65.28% Downside)
Is Verona Pharma Plc Adr (VRNA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 70.65 | Sell |
| STOCH(9,6) | 86.45 | Sell |
| STOCHRSI(14) | 64.36 | Neutral |
| MACD(12,26) | 3.9391 | Buy |
| ADX(14) | 59.24 | Buy |
| William %R | -15.62 | Sell |
| CCI(14) | 57.44 | Neutral |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
57.81
Buy
|
58.24
Buy
|
| MA20 |
54.58
Buy
|
55.18
Buy
|
| MA50 |
47.37
Buy
|
48.85
Buy
|
| MA100 |
40.50
Buy
|
42.09
Buy
|
| MA200 |
29.82
Buy
|
34.16
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, VRNA could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on VRNA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 70.65 indicates that VRNA is overbought. This suggests that VRNA price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 86.45 indicates that VRNA is oversold. This means that VRNA price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.36 indicates that VRNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 59.24 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 57.44 indicates that VRNA is still overbought but not to an extreme extent.
Long-term VRNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Verona Pharma Plc Adr financial reports and earnings history, Verona Pharma Plc Adr (VRNA) stock could reach $24.94 by 2030, $84.85 by 2040 and $91.30 by 2050. See the projected annual prices until 2050 of the Verona Pharma Plc Adr stock below:
- Verona Pharma Plc Adr (VRNA) is expected to reach an average price of $58.32 in 2035, with a high prediction of $59.94 and a low estimate of $56.78. This indicates an $-3.23% rise from the last recorded price of $60.26.
- Verona Pharma Plc Adr (VRNA) stock is projected to chart a bullish course in 2040, with an average price target of $82.15, representing an $36.32% surge from its current level. The forecast ranges from a conservative $80.46 to a sky-high $84.85.
- Our analysts predict Verona Pharma Plc Adr (VRNA) to jump 41.67% by 2045, soaring from $83.46 to an average price of $85.37, potentially reaching $86.05. While $83.46 is the low estimate, the potential upside is significant.
- Verona Pharma Plc Adr (VRNA) stock is expected to climb by 2050, reaching an average of $91.20, a $51.34% jump from its current level. However, a wide range of estimates exists, with high and low targets of $91.30 and $90.53, respectively, highlighting the market's uncertainty.
Verona Pharma Plc Adr Stock (VRNA) Year by Year Forecast
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2025
Verona Pharma Plc Adr Stock (VRNA) is expected to reach an average price of $20.92 in 2025, with a high prediction of $28.25 and a low estimate of $13.59. This indicates an -65.28% fall from the last recorded price of $60.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $17.19 | $16.25 | $18.93 | -71.48% |
| April, 2025 | $15.83 | $13.59 | $17.68 | -73.73% |
| May, 2025 | $16.42 | $15.22 | $16.51 | -72.75% |
| June, 2025 | $16.27 | $15.76 | $18.34 | -73.00% |
| July, 2025 | $17.59 | $16.13 | $18.22 | -70.80% |
| August, 2025 | $17.20 | $16.90 | $18.35 | -71.46% |
| September, 2025 | $20.52 | $16.95 | $28.25 | -65.95% |
| October, 2025 | $19.48 | $18.95 | $21.67 | -67.67% |
| November, 2025 | $19.36 | $19.29 | $20.27 | -67.87% |
| December, 2025 | $19.23 | $18.58 | $19.75 | -68.08% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2026
The predicted value for Verona Pharma Plc Adr (VRNA) in 2026 is set at an average of $21.46. Estimates vary from a peak of $23.95 to a trough of $18.96, indicating an -64.39% surge from the present price of $60.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $20.81 | $18.96 | $21.20 | -65.47% |
| February, 2026 | $21.47 | $20.76 | $21.99 | -64.37% |
| March, 2026 | $21.44 | $20.38 | $21.84 | -64.42% |
| April, 2026 | $23.50 | $21.49 | $23.72 | -61.00% |
| May, 2026 | $22.68 | $22.57 | $23.95 | -62.37% |
| June, 2026 | $23.10 | $21.97 | $23.72 | -61.67% |
| July, 2026 | $20.73 | $20.56 | $23.31 | -65.60% |
| August, 2026 | $22.28 | $20.48 | $22.87 | -63.02% |
| September, 2026 | $20.89 | $20.77 | $22.52 | -65.33% |
| October, 2026 | $21.63 | $20.75 | $21.93 | -64.11% |
| November, 2026 | $21.45 | $20.93 | $22.37 | -64.41% |
| December, 2026 | $21.33 | $20.90 | $22.08 | -64.60% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Verona Pharma Plc Adr (VRNA) is $26.59, with a high forecast of $33.07 and a low forecast of $20.11. This indicates an -55.88% decrease from the last price of $60.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.04 | $20.42 | $21.33 | -65.08% |
| February, 2027 | $21.45 | $21.08 | $21.70 | -64.41% |
| March, 2027 | $21.70 | $20.11 | $22.01 | -64.00% |
| April, 2027 | $23.44 | $21.74 | $23.84 | -61.10% |
| May, 2027 | $22.82 | $22.56 | $23.79 | -62.13% |
| June, 2027 | $22.57 | $22.18 | $23.20 | -62.54% |
| July, 2027 | $22.31 | $21.84 | $22.81 | -62.98% |
| August, 2027 | $21.71 | $21.32 | $22.55 | -63.98% |
| September, 2027 | $22.23 | $21.06 | $22.31 | -63.11% |
| October, 2027 | $22.13 | $22.02 | $23.03 | -63.27% |
| November, 2027 | $22.37 | $21.84 | $22.86 | -62.87% |
| December, 2027 | $31.97 | $22.32 | $33.07 | -46.95% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2028
In 2028, Verona Pharma Plc Adr (VRNA) is projected to reach an average price of $36.57, with a high projection of $45.97 and a low estimate of $27.17. This indicates an -39.31% fall from the last price of $60.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $28.87 | $28.12 | $31.55 | -52.09% |
| February, 2028 | $28.98 | $27.17 | $30.12 | -51.91% |
| March, 2028 | $31.80 | $28.12 | $32.06 | -47.22% |
| April, 2028 | $31.80 | $30.71 | $32.65 | -47.22% |
| May, 2028 | $41.32 | $31.05 | $44.07 | -31.43% |
| June, 2028 | $42.33 | $40.78 | $45.97 | -29.76% |
| July, 2028 | $42.24 | $39.45 | $43.99 | -29.90% |
| August, 2028 | $38.12 | $37.94 | $42.74 | -36.74% |
| September, 2028 | $40.79 | $38.06 | $41.62 | -32.32% |
| October, 2028 | $42.11 | $40.45 | $44.15 | -30.12% |
| November, 2028 | $42.15 | $38.99 | $44.31 | -30.06% |
| December, 2028 | $42.02 | $40.51 | $43.35 | -30.27% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2029
The 2029 price forecast for Verona Pharma Plc Adr Stock (VRNA) is $34.23 on average, with a high prediction of $44.10 and a low estimate of $24.36. This represents an -43.20% decrease from the previous price of $60.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $43.21 | $40.41 | $44.10 | -28.29% |
| February, 2029 | $40.84 | $38.62 | $43.53 | -32.23% |
| March, 2029 | $39.12 | $39.06 | $41.82 | -35.08% |
| April, 2029 | $35.11 | $34.74 | $39.41 | -41.73% |
| May, 2029 | $35.66 | $33.63 | $38.00 | -40.82% |
| June, 2029 | $35.65 | $34.98 | $37.27 | -40.83% |
| July, 2029 | $42.21 | $35.42 | $43.66 | -29.96% |
| August, 2029 | $40.92 | $39.04 | $43.06 | -32.10% |
| September, 2029 | $39.25 | $38.21 | $41.72 | -34.86% |
| October, 2029 | $39.07 | $38.11 | $41.38 | -35.16% |
| November, 2029 | $38.91 | $38.62 | $40.35 | -35.42% |
| December, 2029 | $24.44 | $24.36 | $39.30 | -59.44% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2030
Verona Pharma Plc Adr Stock (VRNA) is expected to reach an average price of $28.93 in 2030, with a high forecast of $34.80 and a low forecast of $23.05. This signifies an -52.00% decrease from the last price of $60.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $24.57 | $24.39 | $24.94 | -59.22% |
| February, 2030 | $24.24 | $24.13 | $24.97 | -59.77% |
| March, 2030 | $24.17 | $23.05 | $24.36 | -59.89% |
| April, 2030 | $24.22 | $23.75 | $25.08 | -59.81% |
| May, 2030 | $25.13 | $24.23 | $25.31 | -58.30% |
| June, 2030 | $25.35 | $24.49 | $25.70 | -57.94% |
| July, 2030 | $25.23 | $25.08 | $26.31 | -58.14% |
| August, 2030 | $26.26 | $25.30 | $26.75 | -56.42% |
| September, 2030 | $28.09 | $26.21 | $34.80 | -53.39% |
| October, 2030 | $29.89 | $27.54 | $30.68 | -50.41% |
| November, 2030 | $26.82 | $26.60 | $30.36 | -55.50% |
| December, 2030 | $27.05 | $25.17 | $28.36 | -55.12% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):